These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21767154)

  • 41. The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model.
    Fullwood RA; Low GM; Chase EP; Grasley M; Beal SS; McCrary IM; Daniels CW; Ingersoll K; Berges BK
    PLoS One; 2018; 13(9):e0204947. PubMed ID: 30265712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
    Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
    PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
    Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
    Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.
    Suthaus J; Stuhlmann-Laeisz C; Tompkins VS; Rosean TR; Klapper W; Tosato G; Janz S; Scheller J; Rose-John S
    Blood; 2012 May; 119(22):5173-81. PubMed ID: 22490805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of viral mimics of cellular genes to KSHV infection and disease.
    Sakakibara S; Tosato G
    Viruses; 2014 Sep; 6(9):3472-86. PubMed ID: 25243371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.
    Wan X; Wang H; Nicholas J
    J Virol; 1999 Oct; 73(10):8268-78. PubMed ID: 10482577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
    Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
    J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted inhibition of angiogenic factors in AIDS-related disorders.
    Aoki Y; Tosato G
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus.
    Großkopf AK; Schlagowski S; Hörnich BF; Fricke T; Desrosiers RC; Hahn AS
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Punjabi AS; Carroll PA; Chen L; Lagunoff M
    J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signal Transduction Pathways Associated with KSHV-Related Tumors.
    Watanabe T; Sugimoto A; Hosokawa K; Fujimuro M
    Adv Exp Med Biol; 2018; 1045():321-355. PubMed ID: 29896674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism.
    Meads MB; Medveczky PG
    J Biol Chem; 2004 Dec; 279(50):51793-803. PubMed ID: 15258150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
    Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
    Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
    Lee HR; Lee S; Chaudhary PM; Gill P; Jung JU
    Future Microbiol; 2010 Sep; 5(9):1349-65. PubMed ID: 20860481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Nakayama R; Ueno Y; Ueda K; Honda T
    Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.